Inflammatory Myoblastic Tumor of Larynx and Trachea: A Case Report
Vishnu Vinayakumar, Manju E Issac, Anjana Bahuleyan, Abraham Varghese, Jayakumar R Menon
Keywords :
Benign tumors of trachea, Case report, Histopathology, Hypopharynx, Inflammatory myoblastic tumor, Inflammatory pseudotumor, Larynx
Citation Information :
Vinayakumar V, Issac ME, Bahuleyan A, Varghese A, Menon JR. Inflammatory Myoblastic Tumor of Larynx and Trachea: A Case Report. Int J Phonosurg Laryngol 2024; 14 (2):37-39.
Inflammatory pseudotumor is a benign, tumor-like lesion of reactive nature. Its basic morphologic characteristic is spindle cell (myoblasts and fibroblasts) proliferation with a variable number and type of inflammatory cells. The newer terminology is inflammatory myoblastic tumor. Although they are mostly reported in the lung parenchyma, tracheal involvement is not unknown. In the past, it was considered benign, but with recent evidence of local recurrence after surgical resection, cases of metastatic spread, and advances in cytogenetic analysis, they are now categorized as tumors with malignant potential. This paper aims to describe a rare case of laryngotracheal inflammatory myoblastic pseudotumor in a young female who had to undergo tracheostomy due to acute airway obstruction, after which the patient underwent complete excision of the tumor along with expansion laryngoplasty.
Zettenger L. Inflammatory pseudotumor in the lung. Nord Med 1971;86:1167–1168.
Manni JJ, Mulder JJ, Schaafsma HE, et al. Inflammatory pseudotumor of the subglottis. Eur Arch Otorhinolaryngol 1992;249(1):16–19. DOI: 10.1007/BF00175664
Wenig BM, Devaney K, Bisceglia M. Inflammatory myofibroblastic tumor of the larynx. A clinicopathologic study of eight cases simulating a malignant spindle cell neoplasm. Cancer 1995;76:2217–2229. DOI: 10.1002/1097-0142(19951201)76:11<2217::aid-cncr2820761107>3.0.co;2-n
Guilemany JM, Alós L, Alobid I, et al. Inflammatory myofibroblastic tumor in the larynx: clinicopathologic features and histogenesis. Acta Otolaryngol 2005;125(2):215–219. DOI: 10.1080/00016480410022796
Suh SI, Seol HY, Lee JH, et al. Inflammatory myofibroblastic tumor of the larynx. Head Neck 2006;28(4):369–372. DOI: 10.1002/hed.20413
WHO Classification of Tumors.
Gaissert HA, Grillo HC, Shadmehr MB, et al. Uncommon primary tracheal tumors. Ann Thorac Surg 2006;82(1):268–272; discussion 272–273. DOI: 10.1016/j.athoracsur.2006.01.065
Amir R, Danahey D, Ferrer K, et al. Inflammatory myofibroblastic tumor presenting with tracheal obstruction in a pregnant woman. Am J Otolaryngol 2002;23(6):362–367. DOI: 10.1053/ajot.2002.128041
Gupta S, Rabold E, Goyal P, et al. Rare cause of recurrent hemoptysis: tracheal myofibroblastoma. Chest 2018;154:612. DOI: 10.1016/j.chest.2018.08.553
Patnana M, Sevrukov AB, Elsayes KM, et al. Inflammatory pseudotumour: the great mimicker. AJR Am J Roentgenol 2012;198:217–227. DOI: 10.2214/AJR.11.7288
Li X, Wei S, Zhou Q, et al. One case of multiple inflammatory pseudotumor in both lungs. Zhongguo Fei Ai Za Zhi 2012;15:246–248. DOI: 10.3779/j.issn.1009-3419.2012.04.10
Rafeek N, Joseph LD, Rajendiran S, et al. Inflammatory myofibroblastic tumour of spermatic cord. Int J Surg Case Rep 2012;3:618–621. DOI: 10.1016/j.ijscr.2012.08.010
Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumour: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31:509–520. DOI: 10.1097/01.pas.0000213393.57322.c7
Rabban JT, Zaloudek CJ, Shekitka KM, et al. Inflammatory myofibroblastic tumour of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumours. Am J Surg Pathol 2005;29:1348–1355. DOI: 10.1097/01.pas.0000172189.02424.91
Alimoglu O, Cevikbas U. Inflammatory pseudotumour of the spleen: report of a case. Surg Today 2003;33:960–964. DOI: 10.1007/s00595-003-2619-y
Bonnet JP, Basset T, Dijoux D. Abdominal inflammatory myofibroblastic tumours in children: report of an appendiceal case and review of the literature. J Pediatr Surg 1996;31:1311–1314. DOI: 10.1016/S0022-3468(96)90262-6
Cook JR, Dehner LP, Collins MH, et al. Anaplastic lymphoma kinase (ALK) expression in the inflammatory myofibroblastic tumour: a comparative immunohistochemical study. Am J Surg Pathol 2001;25(11):1364–1371. DOI: 10.1097/00000478-200111000-00003
Idrees MT, Huan Y, Woo P, et al. Inflammatory myofibroblastic tumor of larynx: a benign lesion with variable morphological spectrum. Ann Diagn Pathol 2007;11(6):433–439. DOI: 10.1016/j.anndiagpath.2007.04.004
Ong HS, Ji T, Zhang CP, et al. Head and neck inflammatory myofibroblastic tumour (IMT): evaluation of clinicopathologic and prognostic features. Oral Oncol 2012;48(2):141–148. DOI: 10.1016/j.oraloncology.2011.09.004
Corsi A, Ciofalo A, Leonardi M, et al. Recurrent inflammatory myofibroblastic tumor of the glottis mimicking malignancy. Am J Otolaryngol 1997;18(2):121–126. DOI: 10.1016/S0196-0709(97)90100-9
Tay SY, Balakrishnan A. Laryngeal inflammatory myofibroblastic tumor (IMT): a case report and review of the literature. J Med Case Rep 2016;10(1):180. DOI: 10.1186/s13256-016-0967-7